Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2023 |
SC 13G
| BlackRock Inc. reports a 7.7% stake in IOVANCE BIOTHERAPEUTICS, INC |
| 02/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/11/2021 |
SC 13G
| ARK Investment Management LLC reports a 10.4% stake in Iovance Biotherapeutics, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2019 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 9.9% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 2.5% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Broadfin Capital, LLC reports a 6.8% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2017 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 6.1% stake in LION BIOTECHNOLOGIES, INC. |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/21/2011 |
SC 13G
| Genesis Biopharma, Inc reports a 5.2% stake in Genesis Biopharma, Inc |
| 02/09/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 12/17/2010 |
SC 13G
| Genesis Biopharma, Inc reports a 8% stake in Genesis Biopharma, Inc. |
| 11/04/2010 |
SC 13G
| Genesis Biopharma, Inc reports a 9.7% stake in Genesis Biopharma, Inc. |
|
|